TrueBlue (TBI) Tops Q4 EPS by 6c

TrueBlue (NYSE: TBI) reported Q4 EPS of $0.66, $0.06 better than the analyst estimate of $0.60. Revenue for the quarter came in at $811 million versus the consensus estimate of $747.5 million.

GUIDANCE:

TrueBlue sees Q1 2016 EPS of $0.23-$0.28, versus the consensus of $0.23.

TrueBlue sees FY2016 EPS of $2.65, versus the consensus of $2.01.

For earnings history and earnings-related data on TrueBlue (TBI) click here.

You May Also Be Interested In

• Pacific Bio (PACB) says prelim. revenue for Q1 was below expectations due to customers delaying instrument purchases
• Ameriserv Financial (ASRV) Reports Q1 EPS of $0.11
• Scilex (SCLX) Provides Preliminary Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024